Cargando…
Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge
OBJECTIVE: We describe the novel case of a patient presenting with pulmonary mucosa-associated lymphoid tissue lymphoma (pMALToma) synchronous with metastatic prostate adenocarcinoma. MATERIALS AND METHODS: We report the clinical, laboratory, radiological and histological findings of the above patie...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417046/ https://www.ncbi.nlm.nih.gov/pubmed/32789141 http://dx.doi.org/10.12890/2020_001711 |
_version_ | 1783569412248305664 |
---|---|
author | Braddy, Aaron Mogal, Rahul Janardan Maddox, Anthony John Barlow, Andrew Bryan Timothy |
author_facet | Braddy, Aaron Mogal, Rahul Janardan Maddox, Anthony John Barlow, Andrew Bryan Timothy |
author_sort | Braddy, Aaron |
collection | PubMed |
description | OBJECTIVE: We describe the novel case of a patient presenting with pulmonary mucosa-associated lymphoid tissue lymphoma (pMALToma) synchronous with metastatic prostate adenocarcinoma. MATERIALS AND METHODS: We report the clinical, laboratory, radiological and histological findings of the above patient. RESULTS: While the patient’s metastatic prostate adenocarcinoma responded well to chemo-radio-hormonal therapy, a persistent area of lung consolidation was noted and further investigated, leading to the diagnosis of concurrent pMALToma. CONCLUSION: It is important to pursue further investigation when there appears to be persistent change or altered disease response in malignancy if there is evidence for disease response elsewhere, as there may be two synchronous primary cancers. LEARNING POINTS: This is a novel case where pulmonary mucosa-associated lymphoid tissue lymphoma (pMALToma), a rare disease entity, presented synchronously and asymptomatically in a patient with metastatic prostate adenocarcinoma. From an instructive errors perspective, it is important to consider synchronous primary malignancy and pursue further investigations, as appropriate, when there appears to be persistent change or altered disease response if there is evidence for disease response elsewhere; |
format | Online Article Text |
id | pubmed-7417046 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-74170462020-08-11 Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge Braddy, Aaron Mogal, Rahul Janardan Maddox, Anthony John Barlow, Andrew Bryan Timothy Eur J Case Rep Intern Med Articles OBJECTIVE: We describe the novel case of a patient presenting with pulmonary mucosa-associated lymphoid tissue lymphoma (pMALToma) synchronous with metastatic prostate adenocarcinoma. MATERIALS AND METHODS: We report the clinical, laboratory, radiological and histological findings of the above patient. RESULTS: While the patient’s metastatic prostate adenocarcinoma responded well to chemo-radio-hormonal therapy, a persistent area of lung consolidation was noted and further investigated, leading to the diagnosis of concurrent pMALToma. CONCLUSION: It is important to pursue further investigation when there appears to be persistent change or altered disease response in malignancy if there is evidence for disease response elsewhere, as there may be two synchronous primary cancers. LEARNING POINTS: This is a novel case where pulmonary mucosa-associated lymphoid tissue lymphoma (pMALToma), a rare disease entity, presented synchronously and asymptomatically in a patient with metastatic prostate adenocarcinoma. From an instructive errors perspective, it is important to consider synchronous primary malignancy and pursue further investigations, as appropriate, when there appears to be persistent change or altered disease response if there is evidence for disease response elsewhere; SMC Media Srl 2020-06-01 /pmc/articles/PMC7417046/ /pubmed/32789141 http://dx.doi.org/10.12890/2020_001711 Text en © EFIM 2020 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Articles Braddy, Aaron Mogal, Rahul Janardan Maddox, Anthony John Barlow, Andrew Bryan Timothy Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge |
title | Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge |
title_full | Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge |
title_fullStr | Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge |
title_full_unstemmed | Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge |
title_short | Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge |
title_sort | pulmonary maltoma synchronous with metastatic prostate adenocarcinoma: a diagnostic challenge |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417046/ https://www.ncbi.nlm.nih.gov/pubmed/32789141 http://dx.doi.org/10.12890/2020_001711 |
work_keys_str_mv | AT braddyaaron pulmonarymaltomasynchronouswithmetastaticprostateadenocarcinomaadiagnosticchallenge AT mogalrahuljanardan pulmonarymaltomasynchronouswithmetastaticprostateadenocarcinomaadiagnosticchallenge AT maddoxanthonyjohn pulmonarymaltomasynchronouswithmetastaticprostateadenocarcinomaadiagnosticchallenge AT barlowandrewbryantimothy pulmonarymaltomasynchronouswithmetastaticprostateadenocarcinomaadiagnosticchallenge |